Haorui Shen
300 Guangzhou Road, Jiangsu
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Circulating NK-cell counts improve prognostic stratification of the PINKE model in extranodal NK/T-cell lymphoma: a retrospective cohort study.
Journal: Leukemia research
Published: May 08, 2026
A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.
Journal: Annals of medicine
Published: March 09, 2026
Dual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohort.
Journal: Haematologica
Published: February 03, 2026
Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial.
Journal: Leukemia
Published: December 25, 2025
A lipid nanoparticle-based peptide-proteolysis-targeting chimera degrades BCL6 for diffuse large B-cell lymphoma treatment.
Journal: Discover oncology
Published: December 06, 2025
Concurrent antiviral-immunochemotherapy strategy safely overcomes high hepatitis B viral load barrier in diffuse large B-cell lymphoma: A multicentre cohort study.
Journal: British journal of haematology
Published: November 10, 2025
Outcomes With First-Line PD1 Inhibitors in Extranodal NK/T-Cell Lymphoma: A Comparative Analysis From a 755-Patient Multicenter Cohort.
Journal: American journal of hematology
Published: October 07, 2025
Penpulimab in combination with lenalidomide and R-GemOx regimen (R2-GemOx-PD1i) in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trial.
Journal: BMC medicine
Published: July 08, 2025
Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy.
Journal: Annals of hematology
Published: November 11, 2023
Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial.
Journal: Chinese medical journal
Published: July 27, 2023
m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 18, 2023
Last Updated: 09/26/2026